ASX 200 set to climb, but dollar remains unclear

While the direction of the dollar remains unclear, the ASX 200 is looking to continue its climb

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The outlook for the Australian dollar remains extremely unclear with economists divided as to where it will stand by mid-2014. In fact, the gap between the highest and lowest estimate is the widest of forecasts between 16 global currencies.

With the dollar currently sitting at US93.76c, some economists predict that it will climb towards parity with the US greenback by mid-next year whilst others believe it will fall to around US80c. These variations are largely based around perspectives of how a Chinese recovery would affect the local economy whilst doubt also lingers over the US Federal Reserve's stimulus program.

The high Australian dollar has proven painful for exporters and other companies which heavily rely upon foreign markets for revenue, which have all been awaiting relief. Miners such as BHP Billiton (ASX: BHP), Rio Tinto (ASX: RIO) or Fortescue Metals Group (ASX: FMG) would certainly benefit from a lower Australian dollar, as would companies including Cochlear (ASX: COH) or Coca-Cola Amatil (ASX: CCL).

The strength of the dollar has also been a major concern for the Reserve Bank of Australia (RBA), which has remained hesitant to lower interest rates to apply downwards pressure on the dollar due to the risk of sparking a housing price bubble. Many analysts have suggested a rate cut could be in line early next year if the dollar does not begin to fall.

In the meantime, however, AMP chief economist Shane Oliver has stated that the dollar would be "buffeted" in the short-term whilst in the medium term the trend was likely to be downwards. Oliver also warned that investors in the stock market should be prepared for a potential correction in prices following a strong rally in recent months, although he remains optimistic that the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) could break through the 5500-point threshold by the end of the year.

Foolish takeaway

The benchmark index is currently residing near a five-year high at just above 5400 points, and many stocks have become overpriced. However, there are still opportunities available!

Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »